These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 13742397)

  • 21. [Clinical studies with 2-sulfanilamido-5-methoxypyrimidine].
    BUENGER P; KOCH G
    Arzneimittelforschung; 1961 Aug; 11():726-36. PubMed ID: 13874434
    [No Abstract]   [Full Text] [Related]  

  • 22. [Our experience with the use of 3-sulfanilamido-2-phenylpyrazole in gynecological practice].
    MILNER A; RODRIGUEZ AE
    Sem Med; 1960 Aug; 117():604-6. PubMed ID: 13770963
    [No Abstract]   [Full Text] [Related]  

  • 23. [New sulfur preparation. On treatment with 4,5-dimethyl-1-2-sulfanilamido-oxazole (Sulfumol)].
    BRANDBERG O; WESSNER G
    Sven Lakartidn; 1962 Mar; 59():995-1000. PubMed ID: 13872472
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of leprosy with 2-sulfanilamido-3-methoxypyrazine (SMPz)].
    Alonso AM
    Rev Bras Med; 1965 May; 22(5):313-20. PubMed ID: 5841420
    [No Abstract]   [Full Text] [Related]  

  • 25. [Preliminary clinico-experimental research on a new sulfonamide: 2-sulfanilamido-3-methoxypyrazine].
    CICERI C; GRASSI C; RIMOLDI R
    Minerva Med; 1961 May; 52():1800-8. PubMed ID: 13693611
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pyrazolic sulfanilamides. IX. Chloro-, methyl- and methoxy-derivatives of 1-phenyl-5-sulfanilamido-pyrazole].
    Alberti C; Tironi C
    Farmaco Sci; 1967 Jan; 22(1):58-75. PubMed ID: 6048934
    [No Abstract]   [Full Text] [Related]  

  • 27. [ON PARTITIONING OF THE SULFONAMIDE, 2-SULFA-3-METHOXYPYRAZINE (SMP) BETWEEN HUMAN SERUM AND CEREBROSPINAL FLUID].
    DETTLI L; SPRING P
    Helv Physiol Pharmacol Acta; 1964 Oct; 64():C112-4. PubMed ID: 14246274
    [No Abstract]   [Full Text] [Related]  

  • 28. [Preliminary results with 2-sulfanilamido-3-methoxypyrazine in pediatric cases].
    COLOMBO GP
    Minerva Med; 1961 May; 52():1808-9. PubMed ID: 13694823
    [No Abstract]   [Full Text] [Related]  

  • 29. [On anti-infective therapy and prevention in aged subjects by prolonged administration of minimal doses of 2-sulfanilamido-3-methoxypyrazine (sulfamethopyrazine)].
    Mars G; Santarato R; Necchi della Silva A
    Minerva Med; 1967 Mar; 58(18):697-700. PubMed ID: 6023813
    [No Abstract]   [Full Text] [Related]  

  • 30. [French contribution to the discovery of hypoglycemic and anti-diabetic properties in certain sulfonamides].
    LOUBATIERES A
    Gaz Med Fr; 1957 Mar; 64(6):505-16. PubMed ID: 13427957
    [No Abstract]   [Full Text] [Related]  

  • 31. [Methodology of chemical control of sulfonamides].
    VLACH J; ROTT M
    Cesk Farm; 1952; 1(10):564-73. PubMed ID: 13009702
    [No Abstract]   [Full Text] [Related]  

  • 32. [Relations between physical parameters and biological activity of organic substances. I. Solubility in water of the amorphous phase of some sulfonamides].
    Avico U; Cavazzutti G; Di Francesco R; Signoretti Ciranni E; Zuccaro P
    Farmaco Prat; 1975 Jan; 30(1):40-6. PubMed ID: 1183572
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of human glanders treated by sulfonamides: development of resistance of the glanders bacillus to sulfonamides during the treatment].
    EGHBAL M; RAFYI A; CHAMSY HM; FARVAR B
    Presse Med (1893); 1953 Nov; 61(75):1535-6. PubMed ID: 13134018
    [No Abstract]   [Full Text] [Related]  

  • 34. Sulfanilamido-s-triazines. I. Synthesis of 2-sulfanilamido-4,6-diethyl-s-triazine and related compounds.
    Taft WE; Krazinski HM; Schaefer FC; Shepherd RG
    J Med Chem; 1965 Nov; 8(6):784-9. PubMed ID: 5885072
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemotherapy with a new, long-acting sulfonamides].
    DENNIG H; WALTZ H
    Med Klin; 1958 Mar; 53(11):419-21. PubMed ID: 13551745
    [No Abstract]   [Full Text] [Related]  

  • 36. [Alteration of postmortem physical-chemical processes by antibiotics and sulfonamides].
    WAGNER HJ
    Dtsch Z Gesamte Gerichtl Med; 1961; 51():572-81. PubMed ID: 14004358
    [No Abstract]   [Full Text] [Related]  

  • 37. [Stability and metabolic investigations of 2-sulfanilamido-4,5-dimethyl-oxazole].
    Büttner H; Portwich F; Seydel J
    Chemotherapy; 1965; 10(1):1-11. PubMed ID: 5860386
    [No Abstract]   [Full Text] [Related]  

  • 38. [Three-week treatment with antidiabetic sulfonamides causing prolonged amelioration in a diabetic].
    GORPE A; GULCULER AC
    Tip Fak Mecm; 1958; 21(1):118-26. PubMed ID: 13569492
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of acute pyelonephritis with sulfonamides (euvernil)].
    IVANYI J
    Med Klin; 1959 Feb; 54(6):221-2. PubMed ID: 13643549
    [No Abstract]   [Full Text] [Related]  

  • 40. [Renal excretion of certain sulfonamide preparations (2-sulfanilamido-4,6-dimethylpyrimidine, 6-sulfanilamido-2,4-dimethylpyrimidine, and sulfapyridine)].
    DUTZ H; KRAUTWALD A; KRETZSCHMAR G
    Z Gesamte Inn Med; 1954 Apr; 9(8):387-93. PubMed ID: 13188094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.